IMMAGE BIOTHERAPEUTICS CORP.: 10-K filed 2015-11-04
What IMMAGE BIOTHERAPEUTICS CORP. reported in its annual report filed 2015-11-04 (fiscal FY 2015): 19 published measures, 49 facts as tagged in accession 0001640334-15-000275.
This filing
- Form
- 10-K (annual report)
- Filed
- 2015-11-04
- Fiscal period
- fiscal FY 2015
- Accession
- 0001640334-15-000275 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All IMMAGE BIOTHERAPEUTICS CORP. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-08-31 | 80,166 | USD | |
| At 2014-09-30 | 2,342 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-08-31 | 28,764 | USD | |
| At 2014-09-30 | -21,615 | USD | |
| At 2013-10-01 | -8,932 | USD | |
| At 2013-09-30 | -8,932 | USD | |
| At 2012-09-30 | -1,921 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-08-31 | 32,678 | USD | |
| At 2014-09-30 | 2,342 | USD | |
| At 2014-08-31 | 2,342 | USD | |
| At 2013-10-01 | 7,215 | USD | |
| At 2013-09-30 | 7,215 | USD | |
| At 2012-09-30 | 5,014 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2015-08-31 | -53,869 | USD | 335 |
| 2013-10-02 to 2014-09-30 | -18,555 | USD | 364 |
| 2013-10-02 to 2014-08-31 | -18,300 | USD | 334 |
| 2012-10-01 to 2013-09-30 | -12,011 | USD | 365 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2015-08-31 | 41,055 | USD | 335 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-08-31 | -86,356 | USD | |
| At 2014-09-30 | -32,487 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-08-31 | 40,370 | USD |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-08-31 | 33,582 | USD | |
| At 2014-09-30 | 2,342 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-08-31 | 51,402 | USD | |
| At 2014-09-30 | 23,957 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-10-02 to 2014-09-30 | 10 | USD | 364 |
| 2013-10-02 to 2014-08-31 | 10 | USD | 334 |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2015-08-31 | 53,869 | USD | 335 |
| 2013-10-02 to 2014-09-30 | 18,555 | USD | 364 |
| 2013-10-02 to 2014-08-31 | 18,300 | USD | 334 |
| 2012-10-01 to 2013-09-30 | 12,011 | USD | 365 |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-08-31 | 41,055 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-08-31 | 685 | USD | |
| At 2014-09-30 | 0 | USD | |
| At 2013-09-30 | 0 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-08-31 | 6,214 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2015-08-31 | 10,969 | USD | 335 |
| 2013-10-02 to 2014-09-30 | 3,728 | USD | 364 |
| 2013-10-02 to 2014-08-31 | 3,728 | USD | 334 |
| 2012-10-01 to 2013-09-30 | 3,116 | USD | 365 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2015-08-31 | 685 | USD | 335 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2015-08-31 | 79 | USD | 335 |
Proceeds from issuing common stock
Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2015-08-31 | 75,000 | USD | 335 |
| 2013-10-02 to 2014-09-30 | 5,882 | USD | 364 |
| 2013-10-02 to 2014-08-31 | 5,882 | USD | 334 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-10-01 to 2015-08-31 | 1,652 | USD | 335 |
| 2013-10-02 to 2014-09-30 | 941 | USD | 364 |
| 2013-10-02 to 2014-08-31 | 686 | USD | 334 |
| 2012-10-01 to 2013-09-30 | 150 | USD | 365 |
Inspect the source
- Entity
- IMMAGE BIOTHERAPEUTICS CORP. / CIK 0001564273
- Captured
- SEC response SHA-256
76b05bb10042aafcff9e5410669c161498d0cb2a1a3e0078501d457e3630a630
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001564273.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))